Citations

Mayo Clinic

Showing 10 of 108572 citations.

Identifying Nuclear Matrix‐Attached DNA Across the Genome
Dobson, Jason R. , Hong, Deli , Wu, Hai , Imbalzano, Anthony N. , Lian, Jane B. , Stein, Janet L. , Wijnen, André J. van , Nickerson, Jeffrey A. , van Wijnen, Andre J, Barutcu, A. Rasim , Stein, Gary S. , van Wijnen, Andre J

Journal of Cellular Physiology | September 14, 2016 | Volume: 232 | Issue: 6 | Pages: 1295-1305

10.1002/jcp.25596 | PMID 27627025 Get It

Experimental approaches to define the relationship between gene expression and nuclear matrix attachment regions (MARs) have given contrasting and method‐specific results. We have developed a next generation sequencing strategy to identify MARs across the human genome (MAR‐Seq). The method is based on crosslinking chromatin to its nuclear matrix attachment sites to minimize changes during biochemical processing. We used this method to compare nuclear matrix organization in MCF‐10A mammary epithelial‐like cells and MDA‐MB‐231 breast cancer cells and evaluated the results in the context of global gene expression (array analysis) and positional enrichment of gene‐regulatory histone modifications (ChIP‐Seq). In the normal‐like cells, nuclear matrix‐attached DNA was enriched in expressed genes, while in the breast cancer cells, it was enriched in non‐expressed genes. In both cell lines, the chromatin modifications that mark transcriptional activation or repression were appropriately associated with gene expression. Using this new MAR‐Seq approach, we provide the first genome‐wide characterization of nuclear matrix attachment in mammalian cells and reveal that the nuclear matrix‐associated genome is highly cell‐context dependent. J. Cell. Physiol. 232: 1295–1305, 2017. © 2016 Wiley Periodicals, Inc.
Patient-Centered Research Priorities for Pulmonary Nontuberculous Mycobacteria (NTM) Infection. An NTM Research Consortium Workshop Report
Henkle, Emily , Aksamit, Timothy R. , Daley, Charles L. , Griffith, David E. , Leitman, Philip, Leitman, Amy, Malanga, Elisha , Marras, Theodore K. , Olivier, Kenneth N., Prevots, D. Rebecca , Prieto, Delia, Skach, William R. , Walsh, John W., Winthrop, Kevin , Aksamit, Timothy, BARKER, ALAN ROBERT , Quittner, Alexandra L.

Annals of the American Thoracic Society | September 14, 2016 | Volume: 13 | Issue: 9 | Pages: S379-S384

10.1513/annalsats.201605-387ws | PMID 27627485 Get It

Abstract Nontuberculous mycobacteria (NTM) cause an increasingly important chronic and debilitating lung disease in older adults. Diagnosis is often delayed, although awareness among clinicians and patients is increasing. When necessary, treatment often lasts 18–24 months and consists of three or four antibiotics that can have serious side effects. Relapses are common and commonly require resumption of prolonged therapy. Given the need for improved diagnostic techniques and clinical trials to identify new therapies or to improve existing therapies, a group of North American clinicians and researchers formed the NTM Research Consortium (NTMRC) in 2014. The NTMRC recognized the importance of including the patient voice in determining research priorities for NTM. In November 2015, patients, caregivers, patient advocates, clinical experts, and researchers gathered for a 1-day meeting in Portland, Oregon funded by the Patient-Centered Outcomes Research Institute. The meeting goal was to define patient-centered research priorities for NTM lung infections. Patients expressed frustration with the number of people who have endured years of missed diagnoses or inadequate treatment of NTM. Participants identified as top research priorities the prevention of NTM infection; approval of more effective treatments with fewer side effects and easier administration; understanding the best chest physiotherapy methods; validating and using tools to measure quality of life; and developing a disease-specific activity and severity assessment tool. Workshop participants agreed that two complementary objectives are critical to ensure the best achievable outcomes for patients: (1) additional clinician education to improve screening and diagnosis of NTM infections; and (2) development of a geographically distributed network of experts in NTM disease to offer consultation or direct therapy after a diagnosis is made.
Hyperthermia for Major Depressive Disorder?
Berk, Michael , Tye, Susannah J. , McGee, Sean L. , Tye, Susannah, Walder, Ken R. , Berk, Michael , Tye, Susannah J

JAMA Psychiatry | September 14, 2016 | Volume: 73 | Issue: 10 | Pages: 1095

10.1001/jamapsychiatry.2016.1532 | PMID 27627184 Get It

Thyroid Cancer Screening in South Korea Increases Detection of Papillary Cancers with No Impact on Other Subtypes or Thyroid Cancer Mortality
Kim, Hyun Jung , Kim, Kyoung Hoon , Lee, Young Sung , Han, Seung Jin , Kim, Yuri , Ko, Min Ji , Brito, Juan P. , Ahn, Hyeong Sik , Brito, Juan P

Thyroid | September 14, 2016 | Volume: 26 | Issue: 11 | Pages: 1535-1540

10.1089/thy.2016.0075 | PMID 27627550 Get It

Sex Related Differences in the Risk of Antibody-Mediated Rejection and Subsequent Allograft Vasculopathy Post-Heart Transplantation: A Single-Center Experience
Grupper, Avishay , Nestorović, Emilija , Daly, Richard C. , Milić, Nataša , Joyce, Lyle D., Stulak, John M., Joyce, David L. , Edwards, Brooks S., Pereira, Naveen L. , Kushwaha, Sudhir S. , Milic, N

Transplantation Direct | September 14, 2016 | Volume: 2 | Issue: 10 | Pages: e106

10.1097/txd.0000000000000616 | PMID 27795988 Get It

Background Pregnancies may result in antibodies against HLA, a risk factor for antibody-mediated rejection (AMR) and subsequent cardiac allograft vasculopathy (CAV) after heart transplantation (HTx). The aim of this study was to evaluate sex differences in the incidence of AMR events and subsequent risk of CAV among HTx recipients. Methods The study comprised 160 patients (51 [32%] women) who underwent HTx in 2008 to 2014. The cumulative effect of AMR events was calculated by AMR score (sum of myocardial biopsy grading divided by number of biopsies taken during 3 years post-HTx). Results Females had higher levels of anti-HLA I antibodies pre-HTx compared to males which was associated with a history of pregnancies, total number of children and with a higher AMR score at 6 months post-HTx (P < 0.05). Women demonstrated a significant increase in the total incidence of AMR events (27 vs. 7%, P = 0.001) and in AMR scores at 6, 12, 24 and 36 months post-HTx compared to men (P < 0.05). There were no differences in cellular rejection between the groups. A history of AMR events was associated with a significantly increased risk of severe CAV onset (hazard ratio, 7.0; 95% confidence interval, 1.5-31.5; P = 0.012). Conclusions Women are at higher risk for AMR post-HTx which subsequently increases their risk for CAV. Females recipients may benefit from closer surveillance to identify AMR at an earlier stage post-HTx, and targeted immunosuppressive therapy to attenuate the development of CAV.
The Fast Zone for Reentry
Asirvatham, Samuel J. , Stevenson, William G. , Asirvatham, Samuel J

Circulation: Arrhythmia and Electrophysiology | September 14, 2016 | Volume: 9 | Issue: 9 | Pages: No page available

10.1161/circep.116.003982 | PMID 27625169 Get It

Variation in Hospital Risk–Adjusted Mortality Rates Following Transcatheter Aortic Valve Replacement in the United States
O’Brien, Sean M. , Rumsfeld, John S., Brennan, James M. , Shahian, David M. , Dai, David , Holmes, David R. , Hakim, Rosemarie B. , Thourani, Vinod H. , Edwards, Fred H., Douglas, Pamela S. , Brennan, J Matthew, Cohen, David Jonathan , Peterson, Eric D. , Douglas, Pamela S

Circulation: Cardiovascular Quality and Outcomes | September 14, 2016 | Volume: 9 | Issue: 5 | Pages: 560-565

10.1161/circoutcomes.116.002756 | PMID 27625404 Get It

Background— The use of transcatheter aortic valve replacement (TAVR) to treat aortic stenosis in the United States is growing, yet little is known about the variation in procedural outcomes in community practice. We developed a TAVR in-hospital mortality risk model and used it to quantify variation in mortality rates across United States (US) TAVR centers. Methods and Results— We analyzed data from 22 248 TAVR procedures performed at 318 sites participating in the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry (November 2011 to October 2014). A Bayesian hierarchical model was developed to estimate hospital-specific risk-adjusted mortality rates adjusting for 40 patient baseline factors. A total of 1130 in-hospital deaths (5.1%) were observed. Reliability-adjusted risk-adjusted mortality rate estimates ranged from 3.4% to 7.7% with an interquartile range of 4.8% to 5.4%. A patient’s predicted odds of dying was 80% higher if treated by a hospital 1 standard deviation above the mean compared with a hospital 1 standard deviation below the mean (odds ratio =1.8; 95% credible interval, 1.4%–2.2%). Conclusions— Risk modeling of TAVR in-hospital mortality revealed variation in risk-adjusted mortality rates during the US early commercial experience. Transcatheter Valve Therapy Registry analyses using this model will support research, feedback reporting, and the identification of factors associated with quality.
Late acute graft-versus-host disease: a prospective analysis of clinical outcomes and circulating angiogenic factors
Holtan, Shernan G. , Khera, Nandita , Levine, John E. , Chai, Xiaoyu , Storer, Barry E. , Liu, Hien , Inamoto, Yoshihiro , Mayer, Sebastian , Arora, Mukta , Palmer, Jeanne , Lukez, Alexander , Arai, Sally , Lazaryan, Aleksandr , Newell, Laura F. , Krupski, Christa , Jagasia, Madan , Pusic, Iskra , Wood, William A. , Renteria, Anne S. , Yanik, Gregory A. , Ayuk, Francis , Holler, Ernst , Watanaboonyongcharoen, Phandee , Efebera, Yvonne A. , Ferrara, James L.M. , Weisdorf, Daniel J. , Lee, Stephanie J. , Pidala, Joseph, Chen, George L. , Flowers, Mary E.D. , Cutler, Corey S. , Hogan, William J. , Hexner, Elizabeth O. , Panoskaltsis‐Mortari, Angela , Weisdorf, Dan , Levine, John E , Holtan, Shernan , Lee, Stephanie J , Wood, William A

Blood | September 14, 2016 | Volume: 128 | Issue: 19 | Pages: 2350-2358

10.1182/blood-2015-09-669846 | PMID 27625357 Get It

Key Points Under current treatment approaches, patients with LA GVHD have poor overall and failure-free survival. Levels of AREG are elevated in LA GVHD, and the AREG/EGF ratio is predictive of overall survival and nonrelapse mortality in LA GVHD.
Impact of religious attendance on psychosocial outcomes for individuals with traumatic brain injury: A NIDILRR funded TBI Model Systems study
Philippus, Angela , Mellick, David, O’Neil-Pirozzi, Therese M. , Bergquist, Thomas F. , Bodien, Yelena G. , Dreer, Laura E. , Novack, Thomas A. , Bergquist, Thomas, Mellick, Dave , Sander, Angelle M. , Giacino, Joseph T. , Dreer, Laura E

Brain Injury | September 13, 2016 | Volume: 30 | Issue: 13-14 | Pages: 1605-1611

10.1080/02699052.2016.1199903 | PMID 27625074 Get It

Evaluating Elevated Hemoglobin—Reply
Scherber, Robyn M. , Mesa, Ruben A.

JAMA | September 13, 2016 | Volume: 316 | Issue: 10 | Pages: 1115

10.1001/jama.2016.11335 | PMID 27623473 Get It